Gyre Therapeutics, Inc. (GYRE)
7.44
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
7.444
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics EPS Diluted (Quarterly) : -0.0189 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neogen Corp. | -0.0781 |
| Zoetis, Inc. | 1.375 |
| Marker Therapeutics, Inc. | -0.1022 |
| Pulmatrix, Inc. | -0.2541 |
| Voyager Therapeutics, Inc. | -0.4653 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.366M |
| Revenue (Quarterly) | 37.20M |
| Total Expenses (Quarterly) | 38.92M |
| Enterprise Value | 664.14M |
| Gross Profit Margin (Quarterly) | 95.31% |
| Profit Margin (Quarterly) | -3.67% |
| Earnings Yield | 0.30% |
| Operating Earnings Yield | 1.55% |
| Normalized Earnings Yield | 0.0511 |